After treatment with hormone therapy and chemotherapy, Mr. Zhang's PSA rebounded three months later and continued chemotherapy, but there was still no improvement, and urinary tract infections and right straddle pain occurred successively. After receiving six ACTL treatments, the PSA dropped and the pain disappeared.

The patient, Mr. Zhang, male, 58 years old, was diagnosed with prostate cancer in September 2014. Check the serum blood tumor marker PSA is 1496, CT scan results showed bone metastasis. In October of the same year, he was given LHRH (Luteinizing Hormone Releasing Hormone) hormone therapy. From January 7th to April 20th, 2015, hormone therapy and chemotherapy (docetaxel) were performed at the same time, and the PSA of the successive tests were (20) (7.7) (2.5) (1.1), and the last test was 0.7 , Is already within the normal range.

In July of the same year, PSA rebounded and rose to 6.3, and received hormone therapy (flutamide), but the effect was not good. From August 31st to September 18th, two consecutive cycles of docetaxel were used, and the PSA was 30 and 67 respectively. Later, due to urinary tract infection, the use of docetaxel was suspended. In November, the PSA value was 140. Docetaxel continued to be used on November 30. In December, the patient reported pain in the right crotch while standing.

At the beginning of 16 years, the patient started ACTL targeted immunotherapy. After treatment, PSA quickly dropped. On April 29, the PSA had dropped to 13. At present, the patient feels good about himself and the pain in his crotch disappears.